Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00184288

Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.

Single Volume 1H MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to investigate the feasibility of in vivo single volume MR spectroscopy in evaluation of treatment response in patients with brain metastases, using 3T MR instrument. In order to optimize and avoid ineffective treatment of patients with brain metastases, in vivo MR spectroscopy can be an useful tool.

Conditions

Timeline

Start date
2004-11-01
Primary completion
2006-06-01
Completion
2010-12-01
First posted
2005-09-16
Last updated
2011-11-02

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00184288. Inclusion in this directory is not an endorsement.

Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response. (NCT00184288) · Clinical Trials Directory